Related Experiment Video
Updated: Aug 6, 2025
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
7.9K
Robot-assisted simple prostatectomy for prostates greater than 100 g.
Vinayak G Wagaskar1, Osama Zaytoun1,2, Priyanka Kale1
1Department of Urology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, 1425 Madison Avenue, New York, NY, 10029, USA.
World Journal of Urology
|March 17, 2023
Summary
Robot-assisted simple prostatectomy (RASP) offers significant improvements in urinary symptoms for benign prostatic hyperplasia. Further comparative studies are needed to evaluate RASP against traditional endoscopic treatments.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Benign prostatic hyperplasia (BPH) treatment is challenging for large prostates.
- Traditional endoscopic options for severe BPH have limitations and complications.
- Robot-assisted simple prostatectomy (RASP) is an emerging alternative.
Purpose of the Study:
- To report initial outcomes of RASP for severe BPH.
- To compare RASP results with existing literature.
- To evaluate RASP in prostates over 100 cc volume.
Main Methods:
- Retrospective analysis of 50 RASP cases (Jan 2014 - May 2021).
- Inclusion criteria: Prostate volume > 100 cc, biopsy-confirmed BPH.
- Data collected: demographics, peri-operative, and post-operative parameters (hospital stay, catheter removal, continence, uroflow).
Main Results:
- Median prostate volume: 167 cc; Median PSA: 7.7 ng/ml.
- RASP showed no intraoperative transfusions or conversions.
- Significant improvements in International Prostate Symptom Score (IPSS) and Qmax observed post-surgery.
Conclusions:
- RASP demonstrates considerable improvement in urinary symptoms for BPH.
- Further comparative studies with endoscopic treatments are warranted.
- Cost-effectiveness analysis of RASP versus endoscopic options is recommended.
